ClinicalTrials.gg
Sign In

Idiopathic Pulmonary Fibrosis clinical trials

The registry lists 577 studies for Idiopathic Pulmonary Fibrosis across more than 10 countries. 124 are recruiting or about to start. 504 of them are mainly about Idiopathic Pulmonary Fibrosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its narrower condition Idiopathic Interstitial Pneumonias too: 584 studies, 124 open.

ClinicalTrials.gov finds 640 studies for Idiopathic Pulmonary Fibrosis. How that becomes 574 here

This page counts the studies the registry files under Idiopathic Pulmonary Fibrosis, and those it files under no condition that list Idiopathic Pulmonary Fibrosisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 640Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −7Filed under a narrower condition, counted on its own pageIdiopathic Interstitial Pneumonias 7
  3. −59Match it another way42 name it in the title and 17 by a synonym or other text the search reads.
  4. 574The count on this page3 of them list Idiopathic Pulmonary Fibrosis in their own words; the registry filed them under no condition.

Get an email when these change. Save the Idiopathic Pulmonary Fibrosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
309
Recruiting
86
Terminated
51
Status unknown
43
Not yet recruiting
33
Active, not recruiting
30

Phase

Phase 2
155
Phase 1
105
Phase 3
59
Phase 4
12
Early Phase 1
9

Where

United States
236
United Kingdom
103
Germany
76
France
70
Italy
68
China
67

Who runs them

Boehringer Ingelheim (36) · Hoffmann-La Roche (16) · Royal Brompton & Harefield NHS Foundation Trust (11) · Bristol-Myers Squibb (9) · GlaxoSmithKline (7) · Assistance Publique - Hôpitaux de Paris (7) · Duke University (7) · Genentech, Inc. (7)

What is being tested here

Drugs under test in Idiopathic Pulmonary Fibrosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pirfenidone2621
Nalbuphine225
Rentosertib214
Rituximab202
Immunoglobulins, Intravenous212
Immunoglobulin G212
TDI01212
Nintedanib1216
Yinfenidone116
Admilparant125

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open · Opioids 2 open · Endothelin receptor antagonists 9

Coming up

16phase 3 studies under way
44studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 86 Idiopathic Pulmonary Fibrosis studies recruiting now, 56 (65%) set no upper age limit and 8 (9%) stop at 75 or younger. 3 (3%) take children under 18. 0 (0%) are for women only and 1 (1%) for men only; 15 (17%) take healthy volunteers.

Recruiting studies that take each age, of 86
AgeWomenMen
103 (3%)3 (3%)
1847 (55%)47 (55%)
3053 (62%)54 (63%)
4082 (95%)83 (97%)
5084 (98%)85 (99%)
6581 (94%)81 (94%)
7580 (93%)80 (93%)
8569 (80%)69 (80%)

Across all 577 studies, recruiting or not: 13% stop at 75 or younger and 8% at 65; 7% take children; <1% are for women only and 1% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Idiopathic Pulmonary Fibrosis studies take

Of 76 phase 2 interventional studies under Idiopathic Pulmonary Fibrosis, half reached primary completion within 30 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 112 mo5–23 · 75 studies10 mo5–16 · 60 studies—
Phase 230 mo21–50 · 76 studies26 mo20–48 · 63 studies—
Phase 335 mo27–60 · 24 studies——
Interventional, no phase26 mo14–53 · 52 studies—27 mo14–53 · 49 studies
Observational51 mo29–96 · 88 studies—58 mo29–102 · 74 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

Results posted1

Stopped1

Newly registered6

Show 1 more

Studies

Recruiting first, then most recently updated. Showing 50 of 577. Browse all 577 → or search them.